Lv1
20 积分 2024-03-21 加入
VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives
5个月前
已完结
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
5个月前
已完结
Developments of CRBN-based PROTACs as potential therapeutic agents
5个月前
已完结
Histone lysine methyltransferase SET8 is a novel therapeutic target for cancer treatment
5个月前
已完结
Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors
5个月前
已完结
Protein Kinases and their Inhibitors Implications in Modulating Disease Progression
5个月前
已完结
Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery
5个月前
已完结
PROTACs: A novel strategy for cancer therapy
5个月前
已完结
Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
5个月前
已完结
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
5个月前
已完结
皖公网安备34019202002308
